These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8083241)

  • 1. A model for the tissue factor pathway to thrombin. I. An empirical study.
    Lawson JH; Kalafatis M; Stram S; Mann KG
    J Biol Chem; 1994 Sep; 269(37):23357-66. PubMed ID: 8083241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
    van 't Veer C; Golden NJ; Kalafatis M; Mann KG
    J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Normal" thrombin generation.
    Butenas S; van't Veer C; Mann KG
    Blood; 1999 Oct; 94(7):2169-78. PubMed ID: 10498586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
    Butenas S; van 't Veer C; Mann KG
    J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for the tissue factor pathway to thrombin. II. A mathematical simulation.
    Jones KC; Mann KG
    J Biol Chem; 1994 Sep; 269(37):23367-73. PubMed ID: 8083242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of factor XI in tissue factor-initiated thrombin generation.
    Butenas S; Dee JD; Mann KG
    J Thromb Haemost; 2003 Oct; 1(10):2103-11. PubMed ID: 14521591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
    van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
    Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation.
    Butenas S; Mann KG
    Biochemistry (Mosc); 2002 Jan; 67(1):3-12. PubMed ID: 11841335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
    van't Veer C; Mann KG
    Semin Thromb Hemost; 2000; 26(4):367-72. PubMed ID: 11092210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN.
    van 't Veer C; Kalafatis M; Bertina RM; Simioni P; Mann KG
    J Biol Chem; 1997 Aug; 272(33):20721-9. PubMed ID: 9252393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
    van 't Veer C; Golden NJ; Mann KG
    Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
    Wielders SJ; Béguin S; Hemker HC; Lindhout T
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
    Chang P; Aronson DL; Borenstein DG; Kessler CM
    Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.